Posts by Tags

-biology

-reproductive

ASHG

ASHG Nascent Transcript November 2018

less than 1 minute read

Published:

For the past 2 years I’ve contributed to the ASHG Trainee Newsletter, the Nascent Transcript. 2018’s 4th quarter edition was published today, and includes my final contribution. I have greatly enjoyed interviewing trainees in the field, collaborating with other trainees through the editing process, flexing my science communication muscles, and curating #ASHGtrainee tweets.

ASHG 2017 and diversity in science

less than 1 minute read

Published:

I had the privilege of interviewing Natalie Telis at the 2017 Annual Meeting of the American Society of Human Genetics. We discussed the topic of her plenary talk, “Scalable computational quantification of gender representation and behavior at ASHG.” The interview was published in the November 2017 ASHG trainee newsletter, the Nascent Transcript.

ASHG Nascent Transcript

less than 1 minute read

Published:

Following last year’s American Society of Human Genetics (ASHG) conference in Vancouver I applied for and was selected to write for the ASHG trainee newsletter, The Nascent Transcript. My first piece, an interview with a genetic counseling trainee, is out today!

ELSI

ASHG Nascent Transcript

less than 1 minute read

Published:

Following last year’s American Society of Human Genetics (ASHG) conference in Vancouver I applied for and was selected to write for the ASHG trainee newsletter, The Nascent Transcript. My first piece, an interview with a genetic counseling trainee, is out today!

Girls Who Code

Girls Who Code celebrates Computer Science Education Week

less than 1 minute read

Published:

Last week was Computer Science Education Week, so naturally I wanted to highlight my favorte CS Ed organization, Girls Who Code at UM Department of Computational Medicine and Bioinformatics! MiSciWriters, the awesome science communication blog at UM, published my article today. Our Executive Committee is really proud of the work we do here in Michigan and the materials we post on Github for other CS educators! Personally, I’m thankful for the women I work with who do amazing research and serve their communities so well. Happy belated CS Education Week!

PCR

ancient DNA

How your electronic medical records could help biomedical research

less than 1 minute read

Published:

Much to the chagrin of many patients in America, digital medical records have phased out paper copies of health records in doctors’ offices across the nation. In my latest blog post for MiSciWriters I make a case for the exciting uses of these digital medical records—called electronic health records (EHRs). The post is the second of a three part series examining ancient DNA, EHRs, and the legacy of Neanderthal DNA in you and me.

big data

circadian rhythym

NHGRI Genome Advance of the Month

less than 1 minute read

Published:

As a postbaccalaurate trainee at the National Human Genome Research Institute I wrote for the Genome Advance of the Month to highlight recent work in the genomics field. This was my first experence with science communication to lay audiences.

computer science

Girls Who Code celebrates Computer Science Education Week

less than 1 minute read

Published:

Last week was Computer Science Education Week, so naturally I wanted to highlight my favorte CS Ed organization, Girls Who Code at UM Department of Computational Medicine and Bioinformatics! MiSciWriters, the awesome science communication blog at UM, published my article today. Our Executive Committee is really proud of the work we do here in Michigan and the materials we post on Github for other CS educators! Personally, I’m thankful for the women I work with who do amazing research and serve their communities so well. Happy belated CS Education Week!

coronavirus

Memorial Day during a pandemic

9 minute read

Published:

Today is Memorial Day in the United States, a day when we honor those who lost their lives in service to our country. It is also a day we approach 100,000 COVID-19 deaths in the U.S. Yesterday, the NY Times memorialized just 1% of those deaths starting on the Sunday front page. If we add every U.S. military death from the beginning of the Korean War in 1950 through all wars and conflicts up to today, we arrive at a similar number of 102,483 deaths (Note: this value is based on this table and could be more or less depending on inclusion of MIA or other nuances). In three months we have lost nearly the amount of Americans as the military personnel we’ve lost in 70 years of conflicts. To memorialize the sacrifice of those who gave their lives for the U.S., we should use our hard-fought freedoms responsibly to help our society and economy move forward as safely as possible in the presence of SARS-CoV-2. I acknowledge that the majority of our country is being conscientious and generous in their sacrifices, and I empathize that everyone has their own unique situation, but we are all interconnected in this pandemic. I believe the following are things we can do to live up to the American way our service members fought and died for.

Extraordinary claims require … evidence

19 minute read

Published:

In this blog post I discuss the credibility of the sources we turn to for evidence, and I provide a curation of resources for readers to explore claims in “Plandemic.” For the scientific community specifically, I summarize and comment on the lessons I’ve learned from “Plandemic”-related discourse the past week. I hope it will be relevant for science communication efforts during the pandemic!

Remdesivir clinical trial & more

7 minute read

Published:

Anecdotal evidence of positive outcomes from the antiviral remdesivir (developed by Gilead Sciences Inc.) have emerged through compassionate use in the previous months, but we needed randomized controlled trials (RCTs) to judge efficacy, or how well the drug worked. A summary of results from a clinical trial in China was inadvertently posted by the World Health Organization last week and did not look too promising. You can read more from TIME. Today, April 29, 2020, a statement was released from the National Institute of Allergy and Infectious Diseases (NIAID) summarizing the preliminary results from the use of remdesivir at 68 international sites. The science and medicine publication, STAT, covered it here. We can’t see the entire methodology to assess the study and analysis limitations, but here is a first pass at what we do know.

News & Views from Quarantine

7 minute read

Published:

You can read my previous pandemic blog posts from April 6, April 2, March 22-25, March 19-21, and March 14-18. As always, you should take everything you read on the internet with a healthy dose of skepticism, and I am not an epidemiologist. But I try to provide relevant evidence from credible sources and use my scientific/statistical training to summarize the highlights of pertinent research with a side of editorialization.

Health disparities and other News & Views from a quarantined scientist

9 minute read

Published:

Today’s blog post comes to you as I hit the three week mark since the last time I was within 6 feet of another human. This isn’t a sacrifice, it is my responsibility as a citizen with privilege to stand in solidarity with those throughout our society who are suffering. I have friends who are health care professionals treating COVID-19 patients without proper PPE, I know people who have lost loved ones to COVID-19, and I know people who have lost jobs. And these are largely people with a lot of privilege.

COVID-19 News and Views from a socially distanced scientist

12 minute read

Published:

As of March 19, 2020 it’s been about a week since widespread closures began in my area—Ann Arbor, Michigan. It’s been 8 days since the World Health Organization declared a pandemic. I’m continuing to curate the top (in my mind) science news and resources here on the blog. You can see my first few days of updates here! I’m trying to add explainers for non-scientists and adding my take on the significance of findings when possible. As with anything on the internet, readers should take my interpretations and editorializations with an ounce of skepticism. What started as advocating for a few weeks of social distancing, now looks more like an effort to present relevant science as humanity battles a potentially long-lasting pandemic. I hope it helps in some way.

covid-19

Memorial Day during a pandemic

9 minute read

Published:

Today is Memorial Day in the United States, a day when we honor those who lost their lives in service to our country. It is also a day we approach 100,000 COVID-19 deaths in the U.S. Yesterday, the NY Times memorialized just 1% of those deaths starting on the Sunday front page. If we add every U.S. military death from the beginning of the Korean War in 1950 through all wars and conflicts up to today, we arrive at a similar number of 102,483 deaths (Note: this value is based on this table and could be more or less depending on inclusion of MIA or other nuances). In three months we have lost nearly the amount of Americans as the military personnel we’ve lost in 70 years of conflicts. To memorialize the sacrifice of those who gave their lives for the U.S., we should use our hard-fought freedoms responsibly to help our society and economy move forward as safely as possible in the presence of SARS-CoV-2. I acknowledge that the majority of our country is being conscientious and generous in their sacrifices, and I empathize that everyone has their own unique situation, but we are all interconnected in this pandemic. I believe the following are things we can do to live up to the American way our service members fought and died for.

Extraordinary claims require … evidence

19 minute read

Published:

In this blog post I discuss the credibility of the sources we turn to for evidence, and I provide a curation of resources for readers to explore claims in “Plandemic.” For the scientific community specifically, I summarize and comment on the lessons I’ve learned from “Plandemic”-related discourse the past week. I hope it will be relevant for science communication efforts during the pandemic!

Remdesivir clinical trial & more

7 minute read

Published:

Anecdotal evidence of positive outcomes from the antiviral remdesivir (developed by Gilead Sciences Inc.) have emerged through compassionate use in the previous months, but we needed randomized controlled trials (RCTs) to judge efficacy, or how well the drug worked. A summary of results from a clinical trial in China was inadvertently posted by the World Health Organization last week and did not look too promising. You can read more from TIME. Today, April 29, 2020, a statement was released from the National Institute of Allergy and Infectious Diseases (NIAID) summarizing the preliminary results from the use of remdesivir at 68 international sites. The science and medicine publication, STAT, covered it here. We can’t see the entire methodology to assess the study and analysis limitations, but here is a first pass at what we do know.

News & Views from Quarantine

7 minute read

Published:

You can read my previous pandemic blog posts from April 6, April 2, March 22-25, March 19-21, and March 14-18. As always, you should take everything you read on the internet with a healthy dose of skepticism, and I am not an epidemiologist. But I try to provide relevant evidence from credible sources and use my scientific/statistical training to summarize the highlights of pertinent research with a side of editorialization.

Health disparities and other News & Views from a quarantined scientist

9 minute read

Published:

Today’s blog post comes to you as I hit the three week mark since the last time I was within 6 feet of another human. This isn’t a sacrifice, it is my responsibility as a citizen with privilege to stand in solidarity with those throughout our society who are suffering. I have friends who are health care professionals treating COVID-19 patients without proper PPE, I know people who have lost loved ones to COVID-19, and I know people who have lost jobs. And these are largely people with a lot of privilege.

COVID-19 News and Views from a socially distanced scientist

12 minute read

Published:

As of March 19, 2020 it’s been about a week since widespread closures began in my area—Ann Arbor, Michigan. It’s been 8 days since the World Health Organization declared a pandemic. I’m continuing to curate the top (in my mind) science news and resources here on the blog. You can see my first few days of updates here! I’m trying to add explainers for non-scientists and adding my take on the significance of findings when possible. As with anything on the internet, readers should take my interpretations and editorializations with an ounce of skepticism. What started as advocating for a few weeks of social distancing, now looks more like an effort to present relevant science as humanity battles a potentially long-lasting pandemic. I hope it helps in some way.

education

Girls Who Code celebrates Computer Science Education Week

less than 1 minute read

Published:

Last week was Computer Science Education Week, so naturally I wanted to highlight my favorte CS Ed organization, Girls Who Code at UM Department of Computational Medicine and Bioinformatics! MiSciWriters, the awesome science communication blog at UM, published my article today. Our Executive Committee is really proud of the work we do here in Michigan and the materials we post on Github for other CS educators! Personally, I’m thankful for the women I work with who do amazing research and serve their communities so well. Happy belated CS Education Week!

gender equality

ASHG 2017 and diversity in science

less than 1 minute read

Published:

I had the privilege of interviewing Natalie Telis at the 2017 Annual Meeting of the American Society of Human Genetics. We discussed the topic of her plenary talk, “Scalable computational quantification of gender representation and behavior at ASHG.” The interview was published in the November 2017 ASHG trainee newsletter, the Nascent Transcript.

genetic counseling

ASHG Nascent Transcript

less than 1 minute read

Published:

Following last year’s American Society of Human Genetics (ASHG) conference in Vancouver I applied for and was selected to write for the ASHG trainee newsletter, The Nascent Transcript. My first piece, an interview with a genetic counseling trainee, is out today!

genetics

Live from Michigan, It’s MiSciWriters

1 minute read

Published:

A lot has changed in the extensive hiatus since my last blog post. I moved from Bethesda, Maryland to Ann Arbor, Michigan. I started a PhD program in Bioinformatics at the University of Michigan. I became a published scientist in a peer-reviewed journal. I picked a thesis laboratory, er, two. However, what hasn’t changed is my desire to communicate science to the public in an effort to increase genetic literacy and ultimately reduce health disparities. In this vein, I have recently become a contributor with MiSciWriters.

Genetic Literacy to Reduce Health Disparities

6 minute read

Published:

For those of you reading this who are familiar with my research interests or career goals, you know that I am driven by a passion for not only cool science, but scientific literacy, specifically in genomics and genetics. For those of you who don’t know me, let me explain.

NHGRI Genome Advance of the Month

less than 1 minute read

Published:

As a postbaccalaurate trainee at the National Human Genome Research Institute I wrote for the Genome Advance of the Month to highlight recent work in the genomics field. This was my first experence with science communication to lay audiences.

health disparities

Live from Michigan, It’s MiSciWriters

1 minute read

Published:

A lot has changed in the extensive hiatus since my last blog post. I moved from Bethesda, Maryland to Ann Arbor, Michigan. I started a PhD program in Bioinformatics at the University of Michigan. I became a published scientist in a peer-reviewed journal. I picked a thesis laboratory, er, two. However, what hasn’t changed is my desire to communicate science to the public in an effort to increase genetic literacy and ultimately reduce health disparities. In this vein, I have recently become a contributor with MiSciWriters.

Genetic Literacy to Reduce Health Disparities

6 minute read

Published:

For those of you reading this who are familiar with my research interests or career goals, you know that I am driven by a passion for not only cool science, but scientific literacy, specifically in genomics and genetics. For those of you who don’t know me, let me explain.

longevity

NHGRI Genome Advance of the Month

less than 1 minute read

Published:

As a postbaccalaurate trainee at the National Human Genome Research Institute I wrote for the Genome Advance of the Month to highlight recent work in the genomics field. This was my first experence with science communication to lay audiences.

medicine

plandemic

Extraordinary claims require … evidence

19 minute read

Published:

In this blog post I discuss the credibility of the sources we turn to for evidence, and I provide a curation of resources for readers to explore claims in “Plandemic.” For the scientific community specifically, I summarize and comment on the lessons I’ve learned from “Plandemic”-related discourse the past week. I hope it will be relevant for science communication efforts during the pandemic!

polygenic risk score

ASHG Nascent Transcript November 2018

less than 1 minute read

Published:

For the past 2 years I’ve contributed to the ASHG Trainee Newsletter, the Nascent Transcript. 2018’s 4th quarter edition was published today, and includes my final contribution. I have greatly enjoyed interviewing trainees in the field, collaborating with other trainees through the editing process, flexing my science communication muscles, and curating #ASHGtrainee tweets.

public health

Memorial Day during a pandemic

9 minute read

Published:

Today is Memorial Day in the United States, a day when we honor those who lost their lives in service to our country. It is also a day we approach 100,000 COVID-19 deaths in the U.S. Yesterday, the NY Times memorialized just 1% of those deaths starting on the Sunday front page. If we add every U.S. military death from the beginning of the Korean War in 1950 through all wars and conflicts up to today, we arrive at a similar number of 102,483 deaths (Note: this value is based on this table and could be more or less depending on inclusion of MIA or other nuances). In three months we have lost nearly the amount of Americans as the military personnel we’ve lost in 70 years of conflicts. To memorialize the sacrifice of those who gave their lives for the U.S., we should use our hard-fought freedoms responsibly to help our society and economy move forward as safely as possible in the presence of SARS-CoV-2. I acknowledge that the majority of our country is being conscientious and generous in their sacrifices, and I empathize that everyone has their own unique situation, but we are all interconnected in this pandemic. I believe the following are things we can do to live up to the American way our service members fought and died for.

Extraordinary claims require … evidence

19 minute read

Published:

In this blog post I discuss the credibility of the sources we turn to for evidence, and I provide a curation of resources for readers to explore claims in “Plandemic.” For the scientific community specifically, I summarize and comment on the lessons I’ve learned from “Plandemic”-related discourse the past week. I hope it will be relevant for science communication efforts during the pandemic!

Remdesivir clinical trial & more

7 minute read

Published:

Anecdotal evidence of positive outcomes from the antiviral remdesivir (developed by Gilead Sciences Inc.) have emerged through compassionate use in the previous months, but we needed randomized controlled trials (RCTs) to judge efficacy, or how well the drug worked. A summary of results from a clinical trial in China was inadvertently posted by the World Health Organization last week and did not look too promising. You can read more from TIME. Today, April 29, 2020, a statement was released from the National Institute of Allergy and Infectious Diseases (NIAID) summarizing the preliminary results from the use of remdesivir at 68 international sites. The science and medicine publication, STAT, covered it here. We can’t see the entire methodology to assess the study and analysis limitations, but here is a first pass at what we do know.

News & Views from Quarantine

7 minute read

Published:

You can read my previous pandemic blog posts from April 6, April 2, March 22-25, March 19-21, and March 14-18. As always, you should take everything you read on the internet with a healthy dose of skepticism, and I am not an epidemiologist. But I try to provide relevant evidence from credible sources and use my scientific/statistical training to summarize the highlights of pertinent research with a side of editorialization.

Health disparities and other News & Views from a quarantined scientist

9 minute read

Published:

Today’s blog post comes to you as I hit the three week mark since the last time I was within 6 feet of another human. This isn’t a sacrifice, it is my responsibility as a citizen with privilege to stand in solidarity with those throughout our society who are suffering. I have friends who are health care professionals treating COVID-19 patients without proper PPE, I know people who have lost loved ones to COVID-19, and I know people who have lost jobs. And these are largely people with a lot of privilege.

COVID-19 News and Views from a socially distanced scientist

12 minute read

Published:

As of March 19, 2020 it’s been about a week since widespread closures began in my area—Ann Arbor, Michigan. It’s been 8 days since the World Health Organization declared a pandemic. I’m continuing to curate the top (in my mind) science news and resources here on the blog. You can see my first few days of updates here! I’m trying to add explainers for non-scientists and adding my take on the significance of findings when possible. As with anything on the internet, readers should take my interpretations and editorializations with an ounce of skepticism. What started as advocating for a few weeks of social distancing, now looks more like an effort to present relevant science as humanity battles a potentially long-lasting pandemic. I hope it helps in some way.

remdesivir

Remdesivir clinical trial & more

7 minute read

Published:

Anecdotal evidence of positive outcomes from the antiviral remdesivir (developed by Gilead Sciences Inc.) have emerged through compassionate use in the previous months, but we needed randomized controlled trials (RCTs) to judge efficacy, or how well the drug worked. A summary of results from a clinical trial in China was inadvertently posted by the World Health Organization last week and did not look too promising. You can read more from TIME. Today, April 29, 2020, a statement was released from the National Institute of Allergy and Infectious Diseases (NIAID) summarizing the preliminary results from the use of remdesivir at 68 international sites. The science and medicine publication, STAT, covered it here. We can’t see the entire methodology to assess the study and analysis limitations, but here is a first pass at what we do know.

scicomm

AWIS Spotlight

less than 1 minute read

Published:

I was honored to be highlighted by the Association of Women in Science (AWIS) at Univeristy of Michgan. The spotlight should you give a sense of my career trajectory (including life as a Natonal Science Foundation Graduate Research Fellow), experiences as a woman in STEM, and my commitment to outreach. Please reach out to me bwolford at umich.edu if you’d like to further discuss life in academia as a woman!

ASHG Nascent Transcript November 2018

less than 1 minute read

Published:

For the past 2 years I’ve contributed to the ASHG Trainee Newsletter, the Nascent Transcript. 2018’s 4th quarter edition was published today, and includes my final contribution. I have greatly enjoyed interviewing trainees in the field, collaborating with other trainees through the editing process, flexing my science communication muscles, and curating #ASHGtrainee tweets.

How your electronic medical records could help biomedical research

less than 1 minute read

Published:

Much to the chagrin of many patients in America, digital medical records have phased out paper copies of health records in doctors’ offices across the nation. In my latest blog post for MiSciWriters I make a case for the exciting uses of these digital medical records—called electronic health records (EHRs). The post is the second of a three part series examining ancient DNA, EHRs, and the legacy of Neanderthal DNA in you and me.

science communication

Memorial Day during a pandemic

9 minute read

Published:

Today is Memorial Day in the United States, a day when we honor those who lost their lives in service to our country. It is also a day we approach 100,000 COVID-19 deaths in the U.S. Yesterday, the NY Times memorialized just 1% of those deaths starting on the Sunday front page. If we add every U.S. military death from the beginning of the Korean War in 1950 through all wars and conflicts up to today, we arrive at a similar number of 102,483 deaths (Note: this value is based on this table and could be more or less depending on inclusion of MIA or other nuances). In three months we have lost nearly the amount of Americans as the military personnel we’ve lost in 70 years of conflicts. To memorialize the sacrifice of those who gave their lives for the U.S., we should use our hard-fought freedoms responsibly to help our society and economy move forward as safely as possible in the presence of SARS-CoV-2. I acknowledge that the majority of our country is being conscientious and generous in their sacrifices, and I empathize that everyone has their own unique situation, but we are all interconnected in this pandemic. I believe the following are things we can do to live up to the American way our service members fought and died for.

Extraordinary claims require … evidence

19 minute read

Published:

In this blog post I discuss the credibility of the sources we turn to for evidence, and I provide a curation of resources for readers to explore claims in “Plandemic.” For the scientific community specifically, I summarize and comment on the lessons I’ve learned from “Plandemic”-related discourse the past week. I hope it will be relevant for science communication efforts during the pandemic!

Remdesivir clinical trial & more

7 minute read

Published:

Anecdotal evidence of positive outcomes from the antiviral remdesivir (developed by Gilead Sciences Inc.) have emerged through compassionate use in the previous months, but we needed randomized controlled trials (RCTs) to judge efficacy, or how well the drug worked. A summary of results from a clinical trial in China was inadvertently posted by the World Health Organization last week and did not look too promising. You can read more from TIME. Today, April 29, 2020, a statement was released from the National Institute of Allergy and Infectious Diseases (NIAID) summarizing the preliminary results from the use of remdesivir at 68 international sites. The science and medicine publication, STAT, covered it here. We can’t see the entire methodology to assess the study and analysis limitations, but here is a first pass at what we do know.

News & Views from Quarantine

7 minute read

Published:

You can read my previous pandemic blog posts from April 6, April 2, March 22-25, March 19-21, and March 14-18. As always, you should take everything you read on the internet with a healthy dose of skepticism, and I am not an epidemiologist. But I try to provide relevant evidence from credible sources and use my scientific/statistical training to summarize the highlights of pertinent research with a side of editorialization.

social distancing

teamscience

twitter

AWIS Spotlight

less than 1 minute read

Published:

I was honored to be highlighted by the Association of Women in Science (AWIS) at Univeristy of Michgan. The spotlight should you give a sense of my career trajectory (including life as a Natonal Science Foundation Graduate Research Fellow), experiences as a woman in STEM, and my commitment to outreach. Please reach out to me bwolford at umich.edu if you’d like to further discuss life in academia as a woman!

women in science

ASHG 2017 and diversity in science

less than 1 minute read

Published:

I had the privilege of interviewing Natalie Telis at the 2017 Annual Meeting of the American Society of Human Genetics. We discussed the topic of her plenary talk, “Scalable computational quantification of gender representation and behavior at ASHG.” The interview was published in the November 2017 ASHG trainee newsletter, the Nascent Transcript.